SCHEMBL5728902

SCHEMBL5728902

NCCCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.67
KCNH2 Q12809 5/20 0.65
CYP2J2 P51589 3/20 0.58
MEN1 O00255 2/20 0.58
NPC1 O15118 1/20 0.58
CACNA1F O60840 1/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
EGFR P00533 1/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
FYN P06241 1/20 0.58
CHRM2 P08172 1/20 0.58
ABCB1 P08183 1/20 0.58
CYP3A4 P08684 1/20 0.58
HTR1A P08908 1/20 0.58
ADRA2A P08913 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
GAA P10253 1/20 0.58
CYP2D6 P10635 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619451 0.96 HRH1 (0.64) HRH1KCNH2CYP2J2MEN1NPC1
SCHEMBL10479209 0.90 HRH1 (0.63) HRH1KCNH2
SCHEMBL5694766 0.87 HRH1 (0.68) HRH1KCNH2CYP2J2MEN1
SCHEMBL11872078 0.86 HRH1 (0.67) HRH1KCNH2CYP2J2MEN1
SCHEMBL9786914 0.85 HRH1 (0.66) HRH1KCNH2CYP2J2MEN1
SCHEMBL16291199 0.84 KCNH2 (0.67) HRH1KCNH2CYP2J2MEN1NPC1
SCHEMBL55533 0.81 HRH1 (0.67) HRH1KCNH2CYP2J2CYP3A4
SCHEMBL10460762 0.81 KCNH2 (0.86) HRH1KCNH2CYP2J2MEN1KMT2A
SCHEMBL5729030 0.80 HRH1 (0.62) HRH1KCNH2CYP2J2HTR1ADRD2
SCHEMBL18609403 0.80 HRH1 (0.80) HRH1KCNH2CYP2J2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1044197-B1 PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKYNE CARBOXAMIDES AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSANTS ASTELLAS PHARMA GMBH (DE) 2006-04-19 EP disclosed
US-6593344-B1 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases KLINGE PHARMA GMBH (DE) 2003-07-15 US disclosed
EP-1044197-A2 NEW PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES Klinge Pharma GmbH (DE) 2000-10-18 EP disclosed
WO-1999031060-A2 PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES AS CYTOSTATICS AND IMMUNESUPPRESSANTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO disclosed